Report Highlights
The U.S amino acids market reached $1.5 billion in 2012. This market is expected to grow to nearly $1.6 billion in 2013 and nearly $2 billion in 2018, a compound annual growth rate (CAGR) of 4.5%.
Report Includes
- An overview of the market for amino acids
- Analyses of market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018
- Identification of those amino acids with current or potentially greater commercial significance
- A look at how new production technology continues to make large-scale production of these products more economical
- Comprehensive profiles of leading companies in the industry.
Report Scope
This technical/market report outlines the properties of the 20 commercial essential amino acids that are delineated in the genetic code, current and future uses, technology and their manufacturers. This report focuses on three commercial amino acid markets: animal feed supplements, flavoring and nutritional additives for human food and specialty uses, including medical, therapeutic, research and industrial applications. Feed and food applications offer steady growth opportunities to their manufacturers and their use will continue to grow as a result of both population increases and an overall increase in the worldwide standard of living.
Analyst Credentials
JON EVANS has been involved in business development and research for the biotechnology industry since 1984. He has been involved in sales, market research and strategy analysis with Fortune 500 clients - with a particular focus on business development challenges and strategies to optimize market performance. He holds a B.S. degree in biology from Rutgers University and MBA in business analysis from San Francisco State University.
Report Highlights
The U.S. market for amino acids represents 20% of the global market with nearly $1.6 billion (in 2011), and is likely to exceed $1.8 billion by 2016, a compound annual growth rate (CAGR) of 2.8% between 2011 and 2016.
Report Highlights
- The global market for protein drugs is expected to increase from an estimated $1.1 billion in 2008 to $1.3 billion in 2013, a compound annual growth rate (CAGR) of 2.9%.
- Amino acids used as flavorants generated an estimated $510.4 million in 2008. This segment should reach $588.2 million in 2013, for a CAGR of 2.9%.
- The animal feeds segment was worth $472.4 million in 2008. This is expected to reach $526.4 million in 2013, for a CAGR of 2.2%.
Report Highlights
-
The U.S. amino acid market will likely surpass $1.5 billion by 2005. Annual growth should be 3.3% on average per year (AAGR) while individual amino acids could see growth spurts.
-
With anticipated 2005 U.S. annual sales exceeding $900 million, the animal feed supplements market will remain the largest market category for amino acids.
-
The four amino acids used as food flavoring agents will account for more than $450 million in 2005.
-
Sales of specialty amino acids used for feeding solutions, pharmaceuticals, biotechnology and medical applications, are expected to rise at an AAGR of 6.5% to about $150 million in 2005.
Report Highlights
-
Twenty amino acids go into making up the commercial amino acid market. This group plays many roles in a variety of fields including foods, animal feeds, cosmetics, medicines, and biotechnology as well as some industrial applications. In dollar terms, the most important current uses are in the animal feed industries and human food uses.
-
The three primary categories of commercial amino acids in the U.S. represented a billion-dollar market for the first time in 1999. The U.S. amino acid market should again surpass the billion-dollar mark in 2000 as factories across the nation and around the world increase production and sales to meet a growing demand. The U.S. amino acid market will likely surpass $1.5 billion by 2005.
-
With anticipated 2000 U.S. annual sales exceeding $800 million, the animal feed supplements market represents the largest market category for amino acids. Export sales of amino acid animal feed supplements will exceed $250 million.
Related Reports
Global Markets for Sugars and Sweeteners in Processed Foods and Beverages
The global market for sugar and other sweeteners was nearly $99.1 billion in 2011 and dropped significantly in 2012 to about $77.5 billion. The market is expected to rise at a CAGR of 4.6% and reach nearly $97.2 billion by 2017.
Global Markets for Chemicals for Cosmetics & Toiletries
The global cosmetic and toiletry ingredients market was valued at $18.7 billion in 2012 and should reach $19.5 billion in 2013. Total market value is expected to reach $24.5 billion in 2018 after increasing at a five-year compound annual growth rate (CAGR) of 4.6%.
Global Markets for Enzymes in Industrial Applications
The global market for industrial enzymes was valued at $3.1 billion in 2009 and reached about $3.6 billion in 2010. The estimated market for 2011 is about $3.9 billion. BCC projects this market to grow at a compounded annual growth rate (CAGR) of 9.1% to reach $6 billion by 2016.
Markets for Advanced Wound Care Technologies
The total market for advanced wound care reached at $3.4 billion in 2010. It is expected to reach at $3.6 billion in 2011; it will further grow to $4.6 billion by 2016 at a compound annual growth rate (CAGR) of 4.9%.
Recent Reports
Exosome Diagnostics, Therapeutics and Research Tools: Global Markets
The global market for exosome diagnostics, therapeutics and research tools is estimated to increase from $227.5 million in 2023 to reach $1.3 billion by 2028, at a compound annual growth rate (CAGR) of 42.2% from 2023 through 2028.
Peptide Synthesis: Global Markets
The global market for peptide synthesis is expected to grow from $90.1 billion in 2023 and projected to reach $157.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.8% during the forecast period of 2023 to 2028.
Oligonucleotides: Global Markets
The global market for oligonucleotides is expected to grow from $7.0 billion in 2023 and projected to reach $11.7 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.0% during the forecast period of 2023 to 2028.
Global Market for Cell and Gene Therapy
The global market for cell and gene therapy is expected to grow from $7.2 billion in 2023 and projected to reach $23.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 26.4% during the forecast period of 2023 to 2028.
Viral Vector and Plasmid DNA: Technologies and Global Markets
The global market for viral vector and plasmid DNA technologies is expected to grow from $2.9 billion in 2023 to $7.1 billion by the end of 2028, at a compound annual growth rate (CAGR) of 19.7% from 2023 through 2028.
Top Trending Reports
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for cell and gene therapy tools and reagents is estimated to grow from $8.3 billion in 2022 to $13.7 billion in 2027, with a compound annual growth rate (CAGR) of 10.6% for the period of 2022-2027.
Flame Retardant Chemicals: Technologies and Global Markets
The global consumption of flame retardant chemicals is estimated to grow from 6.0 billion pounds in 2022 to 7.5 billion pounds in 2027, at a compound annual growth rate (CAGR) of 4.4% for the period of 2022-2027.
Biorefinery Products: Global Markets
The global market for biorefinery products is estimated to increase from $624.7 billion in 2022 to $920.0 billion by 2027, at a compound annual growth rate (CAGR) of 8.0% from 2022 through 2027.
Electric Vehicle Charging: Infrastructure and Global Markets
The global market for wired electric vehicle charging infrastructure is estimated to grow from $24.1 billion in 2022 to $81.1 billion in 2027, at a compound annual growth rate (CAGR) of 27.4% for the period of 2022-2027.
Digital Pathology: Technologies and Global Markets
The global digital pathology market is estimated to increase from $5.9 billion in 2022 to reach $10.7 billion by 2027, at a compound annual growth rate (CAGR) of 12.5% from 2022 through 2027.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More